A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors
Status:
Not yet recruiting
Trial end date:
2026-06-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety, tolerability and PK profile of
HMPL-415S1 and determine MTD and/or RP2D in patients with advanced malignant solid tumor.